TrialTrials2017

Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial.

Priyanga Ranasinghe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.